Successful treatment of rhino-orbital mucormycosis... (2013 study) Skip to main content
Case Report Pediatr Hematol Oncol 2013

Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy

Almannai M, Imran H, Estrada B, Siddiqui A, Pediatr Hematol Oncol, 2013

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors described one toddler with leukemia who developed a serious fungal infection around the eye and nose, and they reported how she was treated.

What They Found

This case report describes a toddler with acute lymphoblastic leukemia who developed rhino-orbital mucormycosis caused by Rhizopus species at the end of induction chemotherapy and who was reported as successfully treated with multiple surgical debridements, amphotericin B, posaconazole and hyperbaric oxygen therapy. Because the treatments were given together, the report cannot show which one contributed to the outcome. The authors state that, to the best of their knowledge, posaconazole combined with hyperbaric oxygen therapy had not been reported before in a toddler with leukemia and invasive Rhizopus infection. They describe this approach as safe and effective in their patient. The abstract gives no numbers, no pressure (ATA) and no session counts.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a report of a single patient with several treatments given together and no comparison group, so it cannot show that any one treatment, including hyperbaric oxygen, caused the recovery.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 23444832
Year Published 2013
Journal Pediatr Hematol Oncol
MeSH Terms Adult; Amphotericin B; Antifungal Agents; Child, Preschool; Combined Modality Therapy; Female; Humans; Hyperbaric Oxygenation; Mucormycosis; Orbital Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Rhizopus; Tomography, X-Ray Computed; Triazoles

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology